ExploreWatchlistsPricing
  1. JP-listed companies
  3. Financials
  4. Net income

(4881)

Market cap
¥2.9B
P/E ratio
Funpep develops new medicines using functional peptides and its STEP UP drug discovery platform, focusing on treatments like SR-0379 for skin ulcers.
SummaryFinancialsDividendsHistoryOwnershipWorkforce
Period EndNet income (Million JPY)YoY (%)
Dec 31, 2025-1,912+115.00%
Dec 31, 2024-889-4.75%
Dec 31, 2023-933-20.39%
Dec 31, 2022-1,173+71.86%
Dec 31, 2021-682+34.32%
Dec 31, 2020-508+115.97%
Dec 31, 2019-235+1870.20%
Dec 31, 2018-12-94.15%
Dec 31, 2017-204-299.61%
Dec 31, 2016102+802.95%
Dec 31, 201511

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat